Generation of a Three-Dimensional in Vitro Ovarian Cancer Co-Culture Model for Drug Screening Assays-Reference-Cited by-同舟云学术

Generation of a Three-Dimensional in Vitro Ovarian Cancer Co-Culture Model for Drug Screening Assays

Published:2021-07 Issue:7 Volume:110 Page:2629-2636
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Tofani Larissa Bueno,Sousa Lucas Oliveira^ORCID,Luiz Marcela Tavares^ORCID,Abriata Juliana Palma^ORCID,Marchetti Juliana Maldonado,Leopoldino Andréia Machado^ORCID,Swiech Kamilla^ORCID

Funder

Coordination of Higher Education Personnel Improvement

CNPq

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line;Villegas-Pineda;Exp Cell Res,2017

2. Ovarian cancer stem cells and their role in drug resistance;Pieterse;Int J Biochem Cell Biol,2019

3. TKTL1 modulates the response of paclitaxel-resistant human ovarian cancer cells to paclitaxel;Zheng;Biochem Biophys Res Commun,2018

4. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells;Li;Eur J Pharmacol,2019

5. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis;Azimian-Zavareh;Exp Cell Res,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them;PeerJ;2024-08-29

2. Current status of in vitro models for rare gynaecological cancer research;European Journal of Surgical Oncology;2024-07

3. Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models;Neuro-Oncology Advances;2024-01-01

4. Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives;Cancer Medicine;2023-09-30

5. The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids;Biomedicine & Pharmacotherapy;2023-09